Wed Sep 18 15:13:00 UTC 2024: ## New Training Program Helps Pharma Companies Navigate Complex Safety Regulations

**Dublin, Sept. 18, 2024** – ResearchAndMarkets.com announces a new training program designed to help pharmaceutical and biologic companies in the US and EU navigate the complex world of product safety regulations. This comprehensive program, titled “Global Regulatory Requirements for Drug Safety & Pharmacovigilance Certification Program,” provides a detailed overview of current safety regulations, focusing on the necessary decision-making processes for reporting incidents to regulatory authorities.

The program emphasizes the importance of understanding the latest US, EU, and UK expectations for compliance and risk assessment, especially in light of the increasing scrutiny on product safety. Participants will learn the vital systems and processes required for effective safety reporting, ensuring they can avoid costly product recalls, maintain international standards, and effectively manage risk.

**Steve Jolley,** a subject matter expert with over 37 years of experience in drug safety and pharmacovigilance, will lead the program. Jolley, who holds degrees from Cambridge University and is an Adjunct Professor at Rutgers University, will share his extensive knowledge on topics such as auditing, signal detection, and data mining.

This training is essential for anyone working in the pharmaceutical and biologic industries who needs to ensure their company is meeting the latest global regulations.

To learn more about this training program, visit [https://www.researchandmarkets.com/r/8dqx39](https://www.researchandmarkets.com/r/8dqx39).

Read More